[EN] NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS<br/>[FR] NOUVEAUC DERIVES ALKYNYL SERVANT DE MODULATEURS DE RECEPTEURS DE GLUTAMATE METABOTROPIQUES
申请人:ADDEX PHARMACEUTICALS SA
公开号:WO2005123703A2
公开(公告)日:2005-12-29
The present invention relates to novel compounds of formula (I) wherein W, n, X and W’ are defined in the description; invention compounds are modulators of metabotropic glutamate receptors - subtype 5 (“mGluR5”) which are useful for the treatment of central nervous system disorders as well as other disorders modulated by mGluR5 receptors.